InvestorsHub Logo
Followers 144
Posts 19364
Boards Moderated 0
Alias Born 06/14/2012

Re: None

Sunday, 03/10/2019 3:59:25 PM

Sunday, March 10, 2019 3:59:25 PM

Post# of 16597
$ETST .735 Alert. DORAL, Florida, March 07, 2019 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, announces that it has engaged Derek Lindsay as a consultant to manage compliance for the potential dual listing of the Company’s common shares on the Canadian Securities Exchange (the “CSE”) in addition to its current listing on the OTCQB.

Derek Lindsay assist ETST with the listing process on the CSE as previously announced by the Company and will implement an investor relation program and other items.
“Dual listing is a major achievement and one that can provide ETST access to new investors and capital,” stated Mr. Lindsay. “Considering that ETST’s R&D division is based in Canada, cross-listing appears well-aligned with the corporate vision. Once this milestone is complete, ongoing efforts will be needed to monitor and ensure compliance, build shareholder value, and communicate with investors. I look forward to supporting the Company in these endeavors.”
Derek Lindsay has solid experience in accelerating the growth of emerging private and public companies, serving as in various capacities that include investor, member of the management team or on the board of directors. His expertise includes capital raising, strategic advice, investor relations and risk management.
ETST President and Chairman Nickolas Tabraue, stated, “We believe Derek’s expertise makes him the perfect fit to ensure that we improve communication with our shareholders and progress on the CSE listing. I plan on sharing further updates as we advance this initiative.”
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
To learn more, please visit: www.EarthScienceTech.com 
ETST currently has two wholly-owned subsidiaries and favored entity focused on developing its role as a world leader in the CBD space, expanding its work in the pharmaceutical and medical device sectors:
Earth Science Pharmaceutical, Inc.
Earth Science Pharmaceutical ("ESP") is a wholly-owned subsidiary of Earth Science Tech, committed to the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP's CEO and chief science officer, Dr. Michel Aubé, is leading the Company’s research and development efforts. The Company’s first medical device, Hygee™, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women. To learn more please visit: www.EarthSciencePharmaceutical.com
Cannabis Therapeutics, Inc.
Cannabis Therapeutics (“CTI”) is a wholly-owned subsidiary of Earth Science Tech, Inc. poised to take a leadership role in the development of new, leading-edge cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs. To learn more please visit: www.CannabisThera.com 
Earth Science Foundation, Inc.
Earth Science Foundation (“ESF”) is a favored entity of Earth Science Tech, Inc. ESF is in the process of becoming a non-profit organization to accept grants and donations to conduct further studies and help donate Earth Science Tech's effective CBD products to those in need. To learn more please visit: www.ETSTFoundtion.org

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.